Juliana Bezerra Medeiros de Lima

Juliana Bezerra Medeiros de Lima


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
JLJuliana Bezerra Medeiros de Lima
Juliana Bezerra Medeiros de Lima
LDLucas Kniess Debarba
Lucas Kniess Debarba
ARAlan C. Rupp
Alan C. Rupp
NQNathan Qi
Nathan Qi
CUChidera Ubah
Chidera Ubah
Marianna SadagurskiMarianna Sadagurski
Marianna Sadagurski
The growth hormone receptor (GHR) is expressed in brain regions that are known to participate in the regulation of energy homeostasis and glucose metabolism. We generated a novel transgenic mouse line (GHRcre) to characterize GHR-expressing neurons specifically in the arcuate nucleus of the hypothalamus (ARC). Here, we demonstrate that ARCGHR+ neurons are co-localized with agouti-related peptide (AgRP), growth hormone releasing hormone (GHRH), and somatostatin neurons, which are activated by GH stimulation. Using the designer receptors exclusively activated by designer drugs (DREADD) technique to control the ARCGHR+ neuronal activity, we demonstrate that the activation of ARCGHR+ neurons elevates a respiratory exchange ratio (RER) under both fed and fasted conditions. However, while the activation of ARCGHR+ promotes feeding, under fasting conditions, the activation of ARCGHR+ neurons promotes glucose over fat utilization in the body. This effect was accompanied by significant improvements in glucose tolerance, and was specific to GHR+ versus GHRH+ neurons. The activation of ARCGHR+ neurons increased glucose turnover and whole-body glycolysis, as revealed by hyperinsulinemic-euglycemic clamp studies. Remarkably, the increased insulin sensitivity upon the activation of ARCGHR+ neurons was tissue-specific, as the insulin-stimulated glucose uptake was specifically elevated in the skeletal muscle, in parallel with the increased expression of muscle glycolytic genes. Overall, our results identify the GHR-expressing neuronal population in the ARC as a major regulator of glycolysis and muscle insulin sensitivity in vivo.

14 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
JLJuliana Bezerra Medeiros de Lima
Juliana Bezerra Medeiros de Lima
CUChidera Ubah
Chidera Ubah
LDLucas Kniess Debarba
Lucas Kniess Debarba
IAIven Ayyar
Iven Ayyar
ODOlesya Didyuk
Olesya Didyuk
Marianna SadagurskiMarianna Sadagurski
Marianna Sadagurski
Many aspects of physiological functions are controlled by the hypothalamus, a brain region that connects the neuroendocrine system to whole-body metabolism. Growth hormone (GH) and the GH receptor (GHR) are expressed in hypothalamic regions known to participate in the regulation of feeding and whole-body energy homeostasis. Sirtuin 1 (SIRT1) is the most conserved mamma-lian nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase that plays a key role in controlling life span and sensing nutrient availability in the hypothalamus in response to caloric restriction. However, the interaction between GHR signaling and SIRT1 in the hypothal-amus is not established. In the arcuate nucleus (ARC) of the hypothalamus, the anorexigenic proopiomelanocortin (POMC)-expressing neurons and the orexigenic agouti-related protein (AgRP)-expressing neurons are the major regulators of feeding and energy expenditure. We show that in the ARC, the majority of GHR-expressing neurons also express SIRT1 and respond to fasting by upregulating SIRT1 expression. Accordingly, hypothalamic upregulation of SIRT1 in response to fasting is blunted in animals with GHR deletion in the AgRP neurons (AgRPEYFPΔGHR). Our data thus reveal a novel interaction between GH and SIRT1 in responses to fasting.

1 January 2021 in Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida
Verified
Journal Article
Open access
RSRafaela Karina Teles Sarmanho
Rafaela Karina Teles Sarmanho
PAPatrick Roberto Gomes Abdoral
Patrick Roberto Gomes Abdoral
LRLarissa Siqueira Rodrigues
Larissa Siqueira Rodrigues
EOEduarda de Melo Rodrigues e Oliveira
Eduarda de Melo Rodrigues e Oliveira
JLJuliana Bezerra Medeiros de Lima
Juliana Bezerra Medeiros de Lima
CCCybelle Silva Do Couto Coelho
Cybelle Silva Do Couto Coelho
OBJETIVO: Avaliar a eficácia da fisioterapia na qualidade de vida em idosos que sofreram queda após intervenção. MÉTODOS: revisão integrativa da literatura acerca da relação entre queda nos idosos e a qualidade de vida. Foram selecionados artigos publicados nas bases de dados PubMed, BVS e Scielo utilizando os descritores: quality of life, aged e accientals fall, nos idiomas português, inglês e espanhol entre os anos 2019 e 2021 sendo selecionados dez artigos relevantes de acordo com os critérios de inclusão e exclusão da pesquisa. RESULTADOS: Entre todos os artigos pesquisados apenas dez se enquadraram nos critérios de inclusão. Foi visto que apesar da expectava de vida nas pessoas idosos terem aumentado não necessariamente eles têm qualidade de vida e foi observado que um grande número de idosos tem medo de sofrer quedas principalmente os que já caíram alguma vez em suas vidas e notou-se que a maior dificuldade encontrada após quedas é a dependência para locomoção e atividades de vida diária. CONCLUSÃO: Observou-se que idosos institucionalizados apresentaram maiores riscos a quedas, diminuição de atividades físicas e menor qualidade de vida em relação aos idosos da comunidade e que fisioterapia através de exercícios de fortalecimento muscular, equilíbrio e propriocepção promovem maior segurança em relação ao medo de cair gerando mais qualidade de vida. DOI: 10.36692/v13n3-15R